Approval · Notice of Compliance 14133 · 2013
COMPONENT TE-H IMPLANTS: Notice of Compliance 14133
Issued February 18, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14133
- Date
- February 18, 2013
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Transfer of DIN ownership
- Therapeutic class
- Growth promotant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT TE-H IMPLANTS | 02244729 | Dormant |
Medicinal ingredients
- ESTRADIOL 14 MG per IMP
- TRENBOLONE ACETATE 140 MG per IMP